| Influenza |
260 |
20% |
| Human papillomavirus |
173 |
13% |
| Pneumococcus |
145 |
11% |
| Hepatitis B |
96 |
7% |
| Rotavirus |
54 |
4% |
| Measles |
50 |
4% |
| Pertussis |
49 |
4% |
| Tetanus toxoid |
41 |
3% |
| Varicella |
37 |
3% |
| Tuberculosis |
35 |
3% |
| Rubella |
33 |
3% |
|
Haemophilus influenzae type b (Hib) |
32 |
2% |
| Poliomyelitis |
29 |
2% |
| Herpes zoster |
26 |
2% |
| Diptheria |
25 |
2% |
| Mumps |
23 |
2% |
| Combination vaccine |
19 |
1% |
| Hepatitis A |
18 |
1% |
| Meningococcal infection |
16 |
1% |
| Cholera |
11 |
1% |
| Yellow fever |
10 |
1% |
| Dengue |
8 |
1% |
| Malaria, Rabies |
7 |
1% |
| Smallpox |
6 |
<1% |
|
Escherichia coli, HIV (each) |
5 |
<1% |
| Japanese encephalitis |
4 |
<1% |
| Hepatitis C, Leishmaniasis, Salmonella (each) |
3 |
<1% |
| Adenovirus, Anthrax, Coxiella burnetii (Q fever), Ebola, Shigella, Tick-borne encephalitis, Typhoid (each) |
2 |
<1% |
|
Campylobacter, Enterovirus vaccine (hand foot and mouth), Herpes simplex, Mycobacterium leprae, Mycobacterium vaccae, Pseudomonas aeruginosa, Respiratory Syncytial Virus (RSV), Streptococcus group B (each) |
1 |
<1% |
| Summary estimates |
|
|
| All systematic reviews |
1285 |
100% |
| On general vaccination/immunization topic |
312 |
24% |
| On disease-specific topic |
973 |
76% |
| On one disease/pathogen area |
859 |
67% |
| On two or more disease/pathogen area |
114 |
9% |
